ESMO Perceptorship H&N cancer Epidemiology, Anatomy and Workup 16 March 2018

Similar documents
De-Escalate Trial for the Head and neck NSSG. Dr Eleanor Aynsley Consultant Clinical Oncologist

Vincent Grégoire, Radiation Oncologist, Brussels, Belgium Cai Grau, Radiation Oncologist, Aarhus, Denmark. Tunis March 2017

Oral Cancer Risk and Detection

EVERYTHING YOU WANTED TO KNOW ABOUT. Robin Billet, MA, CTR, Head & Neck CTAP Member May 9, 2013

HPV and Head and Neck Cancer: What it means for you and your patients

FINE NEEDLE ASPIRATION OF ENLARGED LYMPH NODE: Metastatic squamous cell carcinoma

Head and Neck Cancer in FA: Risks, Prevention, Screening, & Treatment Options David I. Kutler, M.D., F.A.C.S.

Rola brachyterapii w leczeniu wznów nowotworów języka i dna jamy ustnej. The role of brachytherapy in recurrent. oral cavity

TREATMENT TIME & TOBACCO: TWIN TERRORS Of H&N Therapy

Disclosure. Access 10/4/2013. The emerging role of TransOralRobotic Surgery (TORS) Organ preservation in the management of head and neck cancer

Cancer of the Head and Neck and. HPV Infection. Andrew Urquhart MD, FACS Dept. Otolaryngology/Head and Neck Surgery Marshfield Clinic

RADIO- AND RADIOCHEMOTHERAPY OF HEAD AND NECK TUMORS. Zoltán Takácsi-Nagy PhD Department of Radiotherapy National Institute of Oncology, Budapest 1.

Management of unknown primary with neck node metastasis: Current evidence

Nasopharynx. 1. Introduction. 1.1 General Information and Aetiology

Cancer of the Oral Cavity

Evaluation of Whole-Field and Split-Field Intensity Modulation Radiation Therapy (IMRT) Techniques in Head and Neck Cancer

From GTV to CTV: A Critical Step Towards Cure. Kenneth Hu, MD Associate Professor New York University Langone Medical Center June 21, 2017

MANAGEMENT OF LOCALLY ADVANCED OROPHARYNGEAL CANER: HPV AND NON-HPV MEDIATED CANCERS

QUIZZES WITH ANSWERS FOR COLLECTING CANCER DATA: PHARYNX

Practice teaching course on head and neck cancer management

Oral cavity cancer Post-operative treatment

QUIZZES WITH ANSWERS FOR COLLECTING CANCER DATA: PHARYNX

Head & Neck Contouring

Case Scenario. 7/13/12 Anterior floor of mouth biopsy: Infiltrating squamous cell carcinoma, not completely excised.

PILOT STUDY OF CONCURRENT CHEMO-RADIOTHERAPY FOR ADVANCED NASOPHARYNGEAL CARCINOMA (Forum for Nuclear Cooperation in Asia)

Enterprise Interest None

Smoking, human papillomavirus infection, and p53 mutation as risk factors in oropharyngeal cancer: a case-control study

Head & Neck Clinical Sub Group. Network Agreed Imaging Guidelines for UAT and Thyroid Cancer. Measure Nos: 11-1C-105i & 11-1C-106i

International Multispecialty Journal of Health (IMJH) ISSN: [ ] [Vol-3, Issue-9, September- 2017]

REVISITING ICRU VOLUME DEFINITIONS. Eduardo Rosenblatt Vienna, Austria

Head and Neck Cancer Service

Case Scenario 1. 7/13/12 Anterior floor of mouth biopsy: Infiltrating squamous cell carcinoma, not completely excised.

Volumi di trattamento del cavo orale

Oral Cavity Cancer Combined modality therapy

CURRENT STANDARD OF CARE IN NASOPHARYNGEAL CANCER

NASOPHARYNX MALIGNANT NEOPLASM MOHAMMED ALESSA MBBS, FRCSC ASSISTANT PROFESSOR, CONSULTANT OTOLARYNGOLOGY, HEAD & NECK SURGRY KING SAUD UNIVERSITY

Clinical Trials in Transoral Endoscopic Head &Neck Surgery ECOG3311 and RTOG1221. Chris Holsinger, MD, FACS Bob Ferris, MD, PhD, FACS

Locally advanced disease & challenges in management

Quality Variation and Clinical Impact in Head and Neck IMRT

Radiotherapy What are our options and what is on the horizon. Dr Kevin So Specialist Radiation Oncologist Epworth Radiation Oncology

Utilizzo delle tecniche VMAT nei trattamenti del testa collo Marta Scorsetti M.D.

New modalities in the salvage of recurrent nasopharyngeal carcinoma

Pre- Versus Post-operative Radiotherapy

Thomas Gernon, MD Otolaryngology THE EVOLVING TREATMENT OF SCCA OF THE OROPHARYNX

HALF. Who gets radiotherapy? Who gets radiotherapy? Half of all cancer patients get radiotherapy. By 1899 X rays were being used for cancer therapy

Clinical Discussion. Dr Pankaj Chaturvedi. Professor and Surgeon Tata Memorial Hospital

Role of PETCT in the management of untreated advanced squamous cell carcinoma of the oral cavity, oropharynx and hypopharynx

(loco-regional disease)

UPDATE ON RADIOTHERAPY

Survey of Laryngeal Cancer at SBUH comparing 108 cases seen here from to the NCDB of 9,256 cases diagnosed nationwide in 2000

Corporate Medical Policy

CHAPTER I INTRODUCTION. different sites in the head and neck region. The malignancies in mouth, lip,

What is head and neck cancer? How is head and neck cancer diagnosed and evaluated? How is head and neck cancer treated?

Considerations in Managing Recurrent Oral Cancer. I have nothing to disclose

Gynecologic Cancer InterGroup Cervix Cancer Research Network. Management of Cervical Cancer in Resource Limited Settings.

Head and Neck Cancer 2012 COMPARATIVE AUDIT REPORT

Immunotherapy for the Treatment of Head and Neck Cancers. Robert F. Taylor, MD Aurora Health Care

Principles of Management of Head & Neck Cancer. Jinka Sathya Associate professor of Oncology

Greater Baltimore Medical Center Sandra & Malcolm Berman Cancer Institute

Under-appreciated Cancers Associated with HPV Texas Immunization Summit

Nasopharynx Cancer. 1 Feb Presenters: Dr Raghav Murali-Ganesh (Radiation Oncology Registrar) Dr Peter Luk (Pathology Registrar)

Oral HPV infection and the changing epidemiology in head and neck cancer

Management of metastatic squamous cell carcinoma cervical lymphadenopathy with occult primary The role of surgery

Defining Target Volumes and Organs at Risk: a common language

The Evolution of RT Techniques for Gynaecological Cancers in a developing country context

NICE guideline Published: 10 February 2016 nice.org.uk/guidance/ng36

Squamous Cell Carcinoma of the Oral Cavity: Radio therapeutic Considerations

Locoregional recurrences are the most frequent

Role of radiotherapy in the treatment of lymphoma in Lena Specht MD DMSc Professor of Oncology Rigshospitalet, University of Copenhagen Denmark

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES HEAD AND NECK CARCINOMA UNKNOWN PRIMARY

Adjuvant Therapy in Locally Advanced Head and Neck Cancer. Ezra EW Cohen University of Chicago. Financial Support

Notice of Faculty Disclosures

Hypopharynx. 1. Introduction. 1.1 General Information and Aetiology

Goals and Objectives: Head and Neck Cancer Service Department of Radiation Oncology

A Comparison of IMRT and VMAT Technique for the Treatment of Rectal Cancer

BEPERKEN VAN DE BESTRALING TOT EENZIJDIGE HALS MIDDELS SPECT-CT

Oral Cavity and Oropharynx Cancer Trends

Disclosures. HPV and Head and Neck Cancer NONE 5/8/2018

Physician to Physician AJCC 8 th Edition. Head and Neck. Summary of Changes. AJCC Cancer Staging Manual, 7 th Ed. Head and Neck Chapters

Surgical Margins in Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma

Laryngeal Preservation Using Radiation Therapy. Chemotherapy and Organ Preservation

Imaging: When to get MRI, CT or PET-CT?

Head and Neck Reirradiation: Perils and Practice

Intensity Modulated Radiation Therapy (IMRT)

Evaluation and Management of Head and Neck Cancer in Patients with Fanconi anemia David I. Kutler, M.D., F.A.C.S.

Ashley Pyfferoen, MS, CMD. Gundersen Health Systems La Crosse, WI

Head & Neck Staging. Donna M. Gress, RHIT, CTR Technical Editor, AJCC Cancer Staging Manual First Author, Chapter 1: Principles of Cancer Staging

Case Scenario 1. Pathology: Specimen type: Incisional biopsy of the glottis Histology: Moderately differentiated squamous cell carcinoma

Indications and techniques of surgery for the primary treatment of HNSCC

AJCC 8 th Edition Staging. Head & Neck Staging. Learning Objectives. This webinar is sponsored by. the Centers for Disease Control and Prevention.

Cancer of the upper aerodigestive tract: assessment and management in people aged 16 and over

FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX

Locally advanced head and neck cancer

10. HPV-Mediated (p16+) Oropharyngeal Cancer

PET/CT in Gynaecological Cancers. Stroobants Sigrid, MD, PhD Departement of Nuclear Medicine University Hospital,Antwerp

Head and Neck Service

CANCERS of OROPHARYNX and HYPOPHARYNX. STAGING and TREATMENT

Controversies in management of squamous esophageal cancer

The Physics of Oesophageal Cancer Radiotherapy

Transcription:

ESMO Perceptorship H&N cancer Epidemiology, Anatomy and Workup 16 March 2018 Dr. Victor Ho-Fun Lee MBBS, MD, FRCR, FHKCR, FHKAM (Radiology) Clinical Associate Professor Department of Clinical Oncology The University of Hong Kong

Outlines Epidemiology and HNSCC and HPV-positive OPSCC in Hong Kong Important anatomy to oncologists Workup and investigations

Incidence rate of H&N Cancer in Hong Kong (lip, oral cavity and pharynx except NPC) Hong Kong Cancer Registry

Incidence rate of H&N Cancer in Hong Kong (lip, oral cavity and pharynx except NPC) Hong Kong Cancer Registry

Incidence rate of H&N Cancer in Hong Kong (tonsil and oropharynx) Hong Kong Cancer Registry

Incidence rate of H&N Cancer in Hong Kong (tonsil and oropharynx) Hong Kong Cancer Registry

Incidence rate of H&N Cancer in Hong Kong (Hypopharynx+ larynx) Hong Kong Cancer Registry

Incidence rate of H&N Cancer in Hong Kong (Hypopharynx+ larynx) Hong Kong Cancer Registry

HPV positive OPSCC JCO 2016;34:1300-8

JCO 2016;34:1300-8

HPV positivity

Laryngoscope 2016;12:894-900

HPV positivity worldwide Laryngoscope 2016;12:894-900

HPV positivity worldwide Laryngoscope 2016;12:894-900

Local data Cancer Epidemiol Biomarkers Prev 2016;25:165-73

Cancer Epidemiol Biomarkers Prev 2016;25:165-73

Cancer Epidemiol Biomarkers Prev 2016;25:165-73

Cancer Epidemiol Biomarkers Prev 2016;25:165-73

Cancer Epidemiol Biomarkers Prev 2016;25:165-73

Cancer Epidemiol Biomarkers Prev 2016;25:165-73

Our single-centre statistics on HPV positivity at Queen Mary Hospital, Hong Kong 252 patients with cancers of the oropharynx, tonsil and posterior 1/3 of tongue including tongue basetreated at Queen Mary Hospital between 2006 to 2017 Overall 25.4% Tonsil 67.2% (>95% are small T1 tumours) Oropharynx 21.1% Posterior 1/3 of tongue 19.5% HPV routinely checked for all oropharyngeal, tonsillar and post 1/3 tongue cancers

8 th edition AJCC/UICC TNM Curr Treat Options Oncol 2017;18:40

8 th edition AJCC/UICC TNM for HPVpositive OPSCC Curr Treat Options Oncol 2017;18:40

Workup for SCC HPV testing We check for both p16 (oncoprotein) and HPV DNA (past HPV infection) mrna E6/E7 expression should be gold standard but not routinely done due to expensive cost p16 positivity is regarded as HPV-positive tumours in our institution

Other important workup Blood for hematology, biochemistry, hepatitis B serology, creatinine clearance Panendoscopyto rule out occult and synchronous tumoursin upper aerodigestivetract (before and after treatment) Random biopsies for those patients with discernible primary on clinical and imaging examinations CT, MRI head and neck PET-CT scan (90% of our patients) Swallowing assessment Pure-tone audiographyif planned for chemo or chemort

Workup for radiotherapy

Methods of immobilisation Thermoplastic cast

Immobilisationwith thermoplastic cast

Intensity modulated radiation therapy (IMRT) Makes use of multiple beams directed to the tumours at different angles The intensity of radiation dose in each beam can be further modified so as to create a dose gradient to the tumourand the surrounding normal structures (i.e. higher dose to tumourand lower dose to normal structures)

IMRT (tumourcontouring)

PET/CT & MRI co-registration in contouring Primary tumour Left level II LN

PET/CT for diagnosis of subtle synchronous tumour Current retromolar trigone cancer Incidental finding of synchronous submucosal tongue base cancer

Conformal RT employs multiple radiation beams coming in from different angles but all aiming at tumour

IMRT (9-fields) 1 9 2 8 3 7 4 6 5

Volumetric modulated arc therapy (VMAT)

MRI before brachytherapy Brachial plexus And subclavian vessels Brachial plexus And subclavian vessels

Interstitial brachytherapyof neck for NPC neck nodal recurrence

Anatomy important to oncologists

Anatomy important to oncologists

Anatomy important to oncologists

Anatomy important to oncologists

Anatomy important to oncologists

Anatomy important to oncologists

Clivus

Cavernous sinus, dura, temporal lobe and clivus

Retropharyngeal nodes

RP node down to C3/C4 level RP node

Vidiancanal Vidian canal Vidian canal

What s the pathology? NPC?

This pathology is Moderately differentiated squamous carcinoma of the tonsil pt4n2c disease, margins positive HPV p16 positive in retrospective review Surgery followed by post-operative chemoradiation

Another patient

Pathology Panendoscopyand random biopsies of NPC, posterior tongue base, posterior wall of oropharynx, right and left tonsils all negative

Left tonsillectomy Moderately differentiated squamouscell carcinoma Random biopsies may not be sufficient to rule out occult tonsillar cancer

Another patient

Another patient (1)

Another patient (2)

Another patient (3)

Left mandible involved?

Another patient (5)

Checklist for RT planning

Checklist for RT planning

Checklist for RT planning

Summary Incidence of HPV-associated OPSCC in Hong Kong has been catching up with that in Western countries Multi-modality imaging (MRI and PET-CT scan) and panendoscopyare routine investigations for accurate RT planning Proficient knowledge in head and neck anatomy is essential to accurate target contouring in radiotherapy (either as adjuvant or radical definitive treatment)

Thank you